{
    "clinical_study": {
        "@rank": "16728", 
        "acronym": "CRIPS", 
        "arm_group": [
            {
                "arm_group_label": "Therapy group one", 
                "arm_group_type": "Active Comparator", 
                "description": "Lower rate of 60 bpm and out of the box rate response settings of an ADL Rate of 95 bpm and rate profile optimization on with the only change being adjusting the activity threshold from med/low to low."
            }, 
            {
                "arm_group_label": "Therapy group two", 
                "arm_group_type": "Active Comparator", 
                "description": "Rate response programming will be determined by an exercise test consisting of a 2 minute hall walk will be performed at the 2 week follow up and set points will be manually adjusted to achieve an ADL rate of 95 bpm.  Rate Profile Optimization will be turned off. Activity threshold is programmed to low."
            }, 
            {
                "arm_group_label": "Therapy group three", 
                "arm_group_type": "Active Comparator", 
                "description": "Lower rate of 60 bpm and the ADL rate based upon 220- age x 55%.  Activity threshold is programmed to low.  Rate Profile Optimization will be turned ON."
            }
        ], 
        "brief_summary": {
            "textblock": "Providing ideal rate response to patients should improve their quality of life and ability\n      to execute activities of daily living.\n\n      Medtronic pacemakers provide rate response pacing by utilizing dual zone programming to\n      specify an \"activities of daily living\" (ADL) response rate and an \"exertion\" response rate.\n        There is much data to support the target heart rate for an exercise response but the data\n      to support the programming of the ADL rate is lacking."
        }, 
        "brief_title": "A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Sinus Node Dysfunction", 
        "condition_browse": {
            "mesh_term": "Sick Sinus Syndrome"
        }, 
        "detailed_description": {
            "textblock": "Medtronic pacemakers provide rate response pacing by utilizing dual zone programming to\n      specify an \"activities of daily living\" (ADL) response rate and an \"exertion\" response rate.\n        There is much data to support the target heart rate for an exercise response but the data\n      to support the programming of the ADL rate is lacking.\n\n      Unpublished Holter data from our center indicates that the ADL rate for most patients in our\n      practice is between 50-70bpm rather than 95bpm.  Moreover, this increased ADL rate may\n      impact diastolic filling times and adversely impact cardiac output."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of hypertension\n\n          -  Sinus node dysfunction\n\n          -  New implantation of a dual chamber pacemaker due to symptomatic sinus dysfunction or\n             chronotropic incompetence defined as exercise heart rate less than 100 beats per\n             minute\n\n        Exclusion Criteria:\n\n          -  Second or Third degree AV block\n\n          -  Age less than 60 or greater than 95 years\n\n          -  EF less than 45%\n\n          -  Patients that are not ambulatory\n\n          -  Persistent atrial fibrillation (atrial fibrillation lasting greater than 7 days)\n\n          -  Permanent atrial fibrillation (atrial fibrillation lasting great than 1 year)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "95 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02027909", 
            "org_study_id": "CRIPS"
        }, 
        "intervention": {
            "arm_group_label": [
                "Therapy group one", 
                "Therapy group two", 
                "Therapy group three"
            ], 
            "description": "Reprogramming rate response feature in the Medtronic pacemaker to each arm with crossover", 
            "intervention_name": "Reprogramming dual chamber pacemaker", 
            "intervention_type": "Device", 
            "other_name": "Medtronic dual chamber pacemaker"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Sinus Node Dysfunction", 
        "lastchanged_date": "January 2, 2014", 
        "location": {
            "contact": {
                "email": "asparks@mycva.com", 
                "last_name": "Ashley Sparks, LPN", 
                "phone": "423-230-5062"
            }, 
            "contact_backup": {
                "email": "twalker@mycva.com", 
                "last_name": "Terrie Walker, BSN", 
                "phone": "423-230-5643"
            }, 
            "facility": {
                "address": {
                    "city": "Kingsport", 
                    "country": "United States", 
                    "state": "Tennessee", 
                    "zip": "37660"
                }, 
                "name": "Wellmont CVA Heart Institute"
            }, 
            "investigator": {
                "last_name": "Arun Rao, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Comparison of Rate Response Performance in Pacemaker Patients With an Indication of Sinus Node Dysfunction.", 
        "overall_contact": {
            "email": "asparks@mycva.com", 
            "last_name": "Ashley Sparks, LPN", 
            "phone": "423-230-5062"
        }, 
        "overall_contact_backup": {
            "email": "twalker@mycva.com", 
            "last_name": "Terrie Walker, BSN", 
            "phone": "423-230-5643"
        }, 
        "overall_official": {
            "affiliation": "Wellmont CVA Heart Institute", 
            "last_name": "Arun Rao, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Patient report symptoms by clinician interview and patient symptom questionnaire", 
            "measure": "symptom improvement", 
            "safety_issue": "No", 
            "time_frame": "study duration of 9 mths"
        }, 
        "reference": [
            {
                "PMID": "7885929", 
                "citation": "Lau CP, Leung SK. Clinical usefulness of rate adaptive pacing systems: what should we assess? Pacing Clin Electrophysiol. 1994 Dec;17(12 Pt 1):2233-5."
            }, 
            {
                "citation": "Rate adaptive pacing in sick sinus syndrome: Effects of pacing modes. Lau ,C et al. European heart Journal (1994)15:1445-1455."
            }, 
            {
                "PMID": "1712957", 
                "citation": "Oto MA, M\u00fcderrisoglu H, Ozin MB, Korkmaz ME, Karamehmetoglu A, Oram A, Oram E, Ugurlu S. Quality of life in patients with rate responsive pacemakers: a randomized, cross-over study. Pacing Clin Electrophysiol. 1991 May;14(5 Pt 1):800-6."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02027909"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Wellmont CVA Heart Institute", 
            "investigator_full_name": "Arun Rao", 
            "investigator_title": "Arun Rao, MD. FACC", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Two minute hall walk distance Heart rate histograms and sensor indicated rate profile obtained from device interrogation Patient reported symptoms Patient symptom questionnaire Quality of life as measured by SF-36", 
            "measure": "improvement seen on device interrogations and reported improvement of symptoms", 
            "safety_issue": "No", 
            "time_frame": "study duration of 9 mths"
        }, 
        "source": "Wellmont CVA Heart Institute", 
        "sponsors": {
            "collaborator": {
                "agency": "Medtronic", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Arun Rao", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}